🚀 VC round data is live in beta, check it out!
Yifeng Pharmacy Valuation Multiples
Discover revenue and EBITDA valuation multiples for Yifeng Pharmacy and similar public comparables like Clicks Group, Sugi Holdings, Jointown Pharmaceutical, CR Pharmaceutical and more.
Yifeng Pharmacy Overview
About Yifeng Pharmacy
Yifeng Pharmacy Chain Co Ltd is mainly engaged in the chain retail business of medicines, health products, medical devices, and health-related daily convenience products. Its operating segments include the Retail segment and the Wholesale segment.
Founded
2008
HQ
Employees
40.0K
Website
Sectors
Financials (LTM)
EV
$4B
Yifeng Pharmacy Financials
Yifeng Pharmacy reported last 12-month revenue of $4B and EBITDA of $428M.
In the same LTM period, Yifeng Pharmacy generated $1B in gross profit, $428M in EBITDA, and $254M in net income.
Revenue (LTM)
Yifeng Pharmacy P&L
In the most recent fiscal year, Yifeng Pharmacy reported revenue of $4B and EBITDA of $624M.
Yifeng Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 41% | XXX | 40% | XXX | XXX | XXX |
| EBITDA | $428M | XXX | $624M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $254M | XXX | $222M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 6% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Yifeng Pharmacy Stock Performance
Yifeng Pharmacy has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Yifeng Pharmacy's stock price is $3.55.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | 0.2% | XXX | XXX | XXX | $0.18 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialYifeng Pharmacy Valuation Multiples
Yifeng Pharmacy trades at 1.0x EV/Revenue multiple, and 8.9x EV/EBITDA.
EV / Revenue (LTM)
Yifeng Pharmacy Financial Valuation Multiples
As of March 20, 2026, Yifeng Pharmacy has market cap of $4B and EV of $4B.
Equity research analysts estimate Yifeng Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Yifeng Pharmacy has a P/E ratio of 16.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 8.9x | XXX | 6.1x | XXX | XXX | XXX |
| EV/EBIT | 10.2x | XXX | 11.3x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | 2.7x | XXX | XXX | XXX |
| P/E | 16.9x | XXX | 19.4x | XXX | XXX | XXX |
| EV/FCF | 11.4x | XXX | 7.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Yifeng Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Yifeng Pharmacy Margins & Growth Rates
Yifeng Pharmacy's revenue in the last 12 month grew by 10%.
Yifeng Pharmacy's revenue per employee in the last FY averaged $0.1M.
Yifeng Pharmacy's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Yifeng Pharmacy's rule of X is 37% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Yifeng Pharmacy Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | (33%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 25% | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Yifeng Pharmacy Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Clicks Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Sugi Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Jointown Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| CR Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Nahdi Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Yifeng Pharmacy M&A Activity
Yifeng Pharmacy acquired XXX companies to date.
Last acquisition by Yifeng Pharmacy was on XXXXXXXX, XXXXX. Yifeng Pharmacy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Yifeng Pharmacy
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialYifeng Pharmacy Investment Activity
Yifeng Pharmacy invested in XXX companies to date.
Yifeng Pharmacy made its latest investment on XXXXXXXX, XXXXX. Yifeng Pharmacy invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Yifeng Pharmacy
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Yifeng Pharmacy
| When was Yifeng Pharmacy founded? | Yifeng Pharmacy was founded in 2008. |
| Where is Yifeng Pharmacy headquartered? | Yifeng Pharmacy is headquartered in China. |
| How many employees does Yifeng Pharmacy have? | As of today, Yifeng Pharmacy has over 40K employees. |
| Is Yifeng Pharmacy publicly listed? | Yes, Yifeng Pharmacy is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Yifeng Pharmacy? | Yifeng Pharmacy trades under 603939 ticker. |
| When did Yifeng Pharmacy go public? | Yifeng Pharmacy went public in 2015. |
| Who are competitors of Yifeng Pharmacy? | Yifeng Pharmacy main competitors are Clicks Group, Sugi Holdings, Jointown Pharmaceutical, CR Pharmaceutical. |
| What is the current market cap of Yifeng Pharmacy? | Yifeng Pharmacy's current market cap is $4B. |
| What is the current revenue of Yifeng Pharmacy? | Yifeng Pharmacy's last 12 months revenue is $4B. |
| What is the current revenue growth of Yifeng Pharmacy? | Yifeng Pharmacy revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Yifeng Pharmacy? | Current revenue multiple of Yifeng Pharmacy is 1.0x. |
| Is Yifeng Pharmacy profitable? | Yes, Yifeng Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Yifeng Pharmacy? | Yifeng Pharmacy's last 12 months EBITDA is $428M. |
| What is Yifeng Pharmacy's EBITDA margin? | Yifeng Pharmacy's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Yifeng Pharmacy? | Current EBITDA multiple of Yifeng Pharmacy is 8.9x. |
| What is the current FCF of Yifeng Pharmacy? | Yifeng Pharmacy's last 12 months FCF is $334M. |
| What is Yifeng Pharmacy's FCF margin? | Yifeng Pharmacy's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Yifeng Pharmacy? | Current FCF multiple of Yifeng Pharmacy is 11.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.